Sagespring Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.98M Sell
66,315
-160
-0.2% -$18.5K 0.15% 88
2025
Q4
$7M Buy
66,475
+19,946
+43% +$1.87M 0.13% 93
2025
Q3
$3.91M Buy
46,529
+13,778
+42% +$1.13M 0.08% 127
2025
Q2
$2.59M Sell
32,751
-10,958
-25% -$871K 0.06% 152
2025
Q1
$3.92M Sell
43,709
-9,254
-17% -$864K 0.1% 105
2024
Q4
$5.27M Buy
+52,963
New +$5.46M 0.14% 72

Other funds holding MRK

Sagespring Wealth Partners's MRK Position: Q1 2026 in Review

Sagespring Wealth Partners reduced its Merck (MRK) stake by 0.24% in Q1 2026, selling an estimated $18.5K and leaving 66,315 shares worth $7.98M. The position accounts for 0.15% of the portfolio, ranked #88.

Sagespring Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Sagespring Wealth Partners held 66,315 shares of Merck worth $7.98M as of Q1 2026.
  • Sagespring Wealth Partners sold 160 Merck shares in Q1 2026, an estimated $18.5K.
  • Merck made up 0.15% of Sagespring Wealth Partners's portfolio in Q1 2026, its #88 holding.
  • Sagespring Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.